Related Experiment Video
Updated: May 13, 2026
07:40
Preparation of Peripheral Blood Mononuclear Cell Pellets and Plasma from a Single Blood Draw at Clinical Trial Sites for Biomarker Analysis
Published on: March 20, 2021
Biomarkers and drug development 2009.
1Albany Medical College, Department of Pathology, Mail Code 81, 47 New Scotland Avenue, Albany, NY 12208, USA +1 518 262 5461 ; +1 518 262 8092 ; rossj@mail.amc.edu.
Expert Opinion on Medical Diagnostics
|March 19, 2013
Summary
Personalized medicine integrates diagnostic and therapeutic products, driven by public demand for early disease detection and tailored treatments. This collaboration enhances drug efficacy and reduces toxicity.
Area of Science:
- Biotechnology
- Pharmacogenomics
- Clinical Diagnostics
Background:
- Growing public demand for personalized disease risk information and early detection methods.
- Advancements in identifying disease-specific gene and protein biomarkers.
- Emergence of targeted therapies requiring companion diagnostics.
Purpose of the Study:
- To highlight the integration of diagnostic and therapeutic products in personalized medicine.
- To discuss the evolving landscape of drug development and regulatory requirements.
- To outline the opportunities for clinical diagnostic laboratories in this new era.
Main Methods:
- Pharmaceutical companies partnering with diagnostics companies or developing in-house capabilities.
- Focus on disease-specific gene and protein biomarkers for targeted therapies.
- Co-development and co-approval strategies for integrated 'drug and test' products.
Main Results:
- Development of more effective and less toxic personalized medicine products.
- Enhanced efficiency in producing integrated diagnostic and therapeutic solutions.
- Regulatory agencies increasingly requiring co-approval for diagnostic and therapeutic products.
Conclusions:
- The integration of diagnostics and therapeutics represents a significant opportunity for clinical diagnostic laboratories.
- Diagnostic labs can lead in guiding personalized treatment selection, dosage, and combinations.
- This integration promises increased therapeutic efficacy and reduced patient toxicity.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:26Therapeutic Drug Monitoring: Drug Analysis Methods
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
01:20Measurement of Bioavailability: Pharmacodynamic Methods
Pharmacodynamic methods provide insights into a drug's effects on physiological processes over time and play a crucial role in understanding bioavailability and therapeutic efficacy. These methods can be broadly classified into acute pharmacological and therapeutic response approaches, each with distinct mechanisms and applications.The acute pharmacological response method directly correlates a drug's physiological effects, such as ECG or pupil diameter changes, to its time course in the body.
01:16Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
01:23Drug Concentrations: Measurements
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma —...
Plasma —...